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Objective: To investigate the inhibitory effects and the regulatory mechanisms of histone deacetylase
(HDAC) inhibitors on mechanical stress-induced gene expression of runt-related transcription factor
(RUNX)-2 and a disintegrin and metalloproteinase with thrombospondin motif (ADAMTS)-5 in human
chondrocytes.
Methods: Human chondrocytes were seeded in stretch chambers at a concentration of 5 104 cells/
chamber. Cells were pre-incubated with or without HDAC inhibitors (MS-275 or trichostatin A; TSA) for
12 h, followed by uniaxial cyclic tensile strain (CTS) (0.5 Hz, 10% elongation), which was applied for
30 min using the ST-140-10 system (STREX, Osaka, Japan). Total RNA was extracted and the expression of
RUNX-2, ADAMTS-5, matrix metalloproteinase (MMP)-3, and MMP-13 at the mRNA and protein levels
were examined by real-time polymerase chain reaction (PCR) and immunocytochemistry, respectively.
The activation of diverse mitogen-activated protein kinase (MAPK) pathways with or without HDAC
inhibitors during CTS was examined by western blotting.
Results: HDAC inhibitors (TSA: 10 nM, MS-275: 100 nM) suppressed CTS-induced expression of RUNX-2,
ADAMTS-5, and MMP-3 at both the mRNA and protein levels within 1 h. CTS-induced activation of p38
MAPK (p38), extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK) MAPKs was
downregulated by both HDAC inhibitors.
Conclusion: The CTS-induced expression of RUNX-2 and ADAMTS-5 was suppressed by HDAC inhibitors
via the inhibition of the MAPK pathway activation in human chondrocytes. The results of the current
study suggested a novel therapeutic role for HDAC inhibitors against degenerative joint disease such as
osteoarthritis.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The main extracellular matrix (ECM) macromolecules of the
articular cartilage are type II collagen and aggrecan1,2. The disease
progression of osteoarthritis (OA) is a highly complicated process
involving multiple events, including aggrecan and type II collagen
degradation that is caused by increased cleavage due to the: K. Nishida, Department of
nd Reconstruction, Okayama
Pharmaceutical Sciences, 2-
6-235-7273; Fax: 81-86-229-
Nishida).
s Research Society International. Pactivation of proteolytic enzymes, such as matrix metal-
loproteinases (MMPs) and a disintegrin andmetalloproteinasewith
thrombospondin motifs (ADAMTSs). MMPs are induced in chon-
drocytes in response to various stimuli, such as proinﬂammatory
cytokines or mechanical load, and then cleave a variety of ECM
components, including proteoglycans, collagens, and procollagens3.
Currently, ADAMTS-5 is the most efﬁcient in terms of its proteolytic
activity, as previous studies have suggested that ADAMTS-5 may
play a pivotal role in the OA pathogenesis4e6. Loss of type II collagen
and aggrecan degradation are two of the earliest events in the
course of OA following mechanical injury of collagen ﬁbrils7.
Runt-related transcription factor (RUNX) family members
regulate gene expression involved in cellular differentiation
and cell cycle progression. RUNX-2 plays a key role in boneublished by Elsevier Ltd. All rights reserved.
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contributes to OA pathogenesis through chondrocyte hypertrophy
and matrix breakdown after the initiation of joint instability9.
Mitogen-activated protein kinase (MAPK) pathways play essential
regulatory roles in early osteoblast differentiation in response
to mechanical stress via the activation of RUNX-210e13. Several
MAPKs, such as extracellular signal-regulated kinase (ERK), c-Jun
N-terminal kinase (JNK), and p38 MAPK (p38), have been reported
to play a role in osteoblast differentiation14e16. We previously re-
ported that mechanical stress-induced expression of RUNX-2
and ADAMTS-5 is regulated by p38 in a SW1353 human chon-
drosarcoma cell line17.
Recent reports have shown that the epigenetic regulation of
gene expression may be a novel therapeutic approach for
arthritis18,19. Histone deacetylase (HDAC) inhibitors have emerged
as a promising new class of anticancer drugs based on their ability
to activate a variety of genes implicated in the regulation of cell
survival, proliferation, and apoptosis20e23. We previously showed
that the modiﬁcation of histone acetylation by HDAC inhibitors can
successfully ameliorate synovial inﬂammation via the upregulation
in synovial ﬁbroblasts of cell cycle regulators in an animal arthritis
model24. Interestingly, the expression of MMP-3 and MMP-13 was
effectively downregulated, leading to the abrogation of cartilage
destruction in mouse models25. However, whether HDAC inhibitors
directly contribute to the prevention of cartilage matrix degrada-
tion has not been fully elucidated.
In the current study, the effect of HDAC inhibitors on the
mechanical stress-induced gene expression of RUNX-2, ADAMTS-5,
and MMP-3 was examined in vitro using human chondrocytes. Our
ﬁndings provide further evidence that HDAC inhibitors may have
a role in the suppression of cartilage degeneration through the
inhibition of mechanical stress-induced proteolytic enzymes.
Materials and methods
Cells and cell culture
Normal human articular chondrocytes (NHAC-kn cells) ob-
tained from a 45-year-old male were purchased from Lonza
(Walkersville, MD, USA). Cells were cultured in 15 mL of chon-
drocyte basal medium (CBM; Lonza) containing supplements and
several growth factors [Revitropin e long R3 insulin-like growth
factor (R3-IGF-1), basic ﬁbroblast growth factor (bFGF), tranferrin,
insulin, fetal bovine serum (FBS), and gentamicin/amphotericin-B;
CGM singleQuots, Lonza] and were then subcultured at split
ratios of 1:3 using trypsin plus ethylenediaminetetraacetic acid
(EDTA) every 6e7 days. The medium was changed every 3 days.
The cells were subcultured for two passages and cells at the third
passage were used for experiments within 2 weeks after starting
the cell cultures. For all experiments, human chondrocytes were
transferred to serum-free a-modiﬁed minimum essential medium
(MEMa, Wako, Osaka, Japan) for 12 h before exposure to different
stimuli.
Cyclic tensile strain (CTS) on chondrocytes cultured in monolayer
Human chondrocytes were seeded in stretch chambers coated
with ﬁbronectin at a concentration of 5104 cells/chamber; each
chamber had a culture surface of 2 2 cm. Mechanical stresses
were applied using the ST-140-10 mechanical stretch system
(STREX, Osaka, Japan). The chamber was attached to the stretching
apparatus, which has one ﬁxed side opposite a movable side that
can be driven by a computer-controlled motor. By using this
apparatus, the entire silicon membrane area and almost all cells
on the stretch chambers can be stretched uniformly26,27. Afterculturing for 48 h, the cells increased to 60% conﬂuence in the
chamber. In the current study, a CTS (0.5 Hz, 10% elongation) was
applied for 30 min according to our previous study17. To apply
mechanical stress, cells were cultured in stretch chambers, and set
on the ST-140-10 system in an incubator (Supplemental Fig.1). Cells
without mechanical stress were seeded on the same chambers, and
used as controls.
Treatment with HDAC inhibitors
We used two HDAC inhibitors: trichostatin A (TSA; Sigmae
Aldrich, Oakville, Ontario, Canada), a general HDAC inhibitor, and
MS-275 (Cayman Chemical, Ann Arbor, MI, USA), a class I HDAC
speciﬁc inhibitor. All inhibitors were used at various concentrations
for 12 h before CTS. TSA and MS-275 were dissolved in dimethyl
sulfoxide (DMSO) and then diluted with phosphate buffered saline
(PBS) to a working concentration up to 500 mM.
Cell proliferation assay
Cells were incubatedwith or without TSA andMS-275 at various
concentrations (10, 100, 500 nM) for 12 h before CTS. Cell viability
was evaluated at 1 h after CTS, using the colorimetric MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a yellow
tetrazole) assay (Chemicon, Temecula, CA, USA) according to the
manufacturer’s instructions. The experiments were repeated six
times.
Reverse transcription polymerase chain reaction (RT-PCR) and real-
time PCR analysis
We examined the effect of CTS and HDAC inhibitors on RUNX-2,
MMP-3, MMP-13, and ADAMTS-5 expression in human chon-
drocytes by RT-PCR and real-time PCR. The half-life of the type II
collagen a1 chain (COL2A1) mRNA is reported to be approximately
15 h28,29; therefore, we used COL2A1 expression using real-time
PCR at 15 h after CTS as a positive control.
After stimulation, the cells werewashedwith PBS, and total RNA
was extracted using ISOGEN reagent (Nippon Gene, Toyama, Japan),
according to the manufacturer’s protocol. The concentration and
purity of total RNA were assayed by spectrophotometry. To make
complementary DNA (cDNA), 1 mg of total RNA was reverse tran-
scribed using ReverTra Ace, a Moloney murine leukemia virus
reverse transcriptase, with Oligo-dT primers, according to the
manufacturer’s instructions (TOYOBO, Tokyo, Japan). The cDNAwas
PCR-ampliﬁed using 10 pmol of each speciﬁc primer and ExTaq
DNA polymerase (TAKARA BIO, Shiga, Japan). The sequences of the
oligonucleotide primers are shown in Table I (COL2A1, RUNX-2,
MMP-3, MMP-13, glyceraldehyde-3-phosphate dehydrogenase
(G3PDH) and ADAMTS-5). For all RT-PCR fragments, the reactions
were allowed to proceed for 35 cycles (30 cycles for G3PDH) in
a T3000 thermocycler (Biometra, Göttingen, Germany).
Real-time PCR was performed using an Mx3000P QPCR System
(Agilent Technologies, Santa Clara, CA, USA) with Brilliant III Ultra-
Fast SYBR Green QPCR Master Mix. The PCR mixture was in a total
volume of 20 mL and consisted of 1 SYBR Green PCR Master
Mix, which included DNA polymerase, SYBR Green dye, dNTPs
(including dUTP), PCR buffer, 10 pmol each of the forward and
reverse primers, and cDNA of the samples. Ampliﬁcation of
a housekeeping gene, G3PDH, was used for normalizing the efﬁ-
ciency of cDNA synthesis and the amount of RNA.We calculated the
ﬁnal expression levels by dividing the expression level of RUNX-2,
MMP-3, MMP-13, and ADAMTS-5 by the expression level of G3PDH.
Each value obtained for the control cells (un-stretched cells
without HDAC inhibitors) was set to 1.
Table I
Primer pairs for RT-PCR and real-time PCR detection
Gene Nucleotide sequence NCBI gene
no.
Annealing
tm
COL2A1 F AAT TCC TGG AGC
CAA AGG AT
NM_001844 55C
R AGG ACC AGT TGC
ACC TTG AG
RUNX-2 F CTC TAC CAC CCC
GCT GTC TT
NM_004348 55C
R CAC CTG CCT GGC
TCT TCT TAC
ADAMTS-5 F TAT GAC AAG TGC
GGA GTA TG
NM_007038 60C
R TTC AGG GCT AAA
TAG GCA GT
MMP-3 F ATG CCC ACT TTG
ATG ATG ATG AAC
NM_002422 60C
R CCA CGC CTG AAG
GAA GAG ATG
MMP-13 F ACC CTG GAG CAC
TCA TGT TTC CTA
NM_002427 60C
R TGG CAT CAA GGG
ATA AGG AAG GGT
G3PDH F CAT CAA GAA GGT
GGT GAA GCA G
NM_002046 60C
R CGT CAA AGG TGG
AGG AGT GG
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Immunocytochemistry was used to observe the mechanical
stress-induced expression and localization of RUNX-2 and
ADAMTS-5. Cells were loaded for 30 min by CTS (0.5 Hz, 10%
elongation) with or without HDAC inhibitors (TSA: 10 nM, MS-275:
100 nM) and then ﬁxed with 1% paraformaldehyde solution. The
chambers were incubated with anti-RUNX-2 antibody (10 mg/mL,
ab76956, Abcam, Cambridge, UK) and anti-human ADAMTS-5
antibody (10 mg/mL, R&D Systems, Minneapolis, MN, USA) for
120 min at room temperature. Bovine serum albumin-containing
solutions without primary antibodies were used as negative
controls. We used Alexa Fluor 488-conjugated antibody (10 mg/mL,
anti-mouse), Alexa Fluor 568-conjugated phalloidin (2 mg/mL,
Molecular Probes, Eugene, OR, USA), and Hoechst 33342 (1 mg/mL,
ICN Biomedicals, Aurora, OH, USA) as secondary antibodies.
Samples were evaluated under a ﬂuorescence microscope (Leica,
Wetzlar, Germany), and protein expression was evaluated by the
positive cell ratio of RUNX-2 or ADAMTS-5 (number of positive
cells/all cells). The cell number counting was done in four ﬁelds, at
100 magniﬁcation, and averaged.
Western blot analysis and protein kinase inhibitor assay
All cells were incubated in 1 mL of CBM containing 10% FBS on
2 2 cm stretch chambers. After 24 h, the mediumwas changed toTable II
The effects of TSA and MS-275 on the viability of human chondrocytes as determined by
CTS  þ þ þ
TSA   10 
MS-275    10
Mean folds of control 1.00 1.23* 1.11* 1.33*
95% CI 1.16e1.30 1.03e1.18 1.25e
The data are presented as the mean with 95% CI of six times determinations. *P< 0.01, rserum-free MEMa, and the cells were incubated overnight. For
western blot analysis, cells were stretched by CTS (0.5 Hz, 10%
elongation) for 30 min using the ST-140-10 systemwith or without
HDAC inhibitors (TSA: 10 nM, MS-275: 100 nM). Cell lysates (10 mg
of total protein/lane, 15 mg/lane for RUNX-2 and phospho-RUNX-2)
were subjected to sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) using a 10% gel and then transferred
onto polyvinylidene diﬂuoride membranes (Bio-Rad Laboratories,
Hercules, CA, USA). The membranes were incubated with blocking
reagent (TOYOBO) and incubated overnight at 4C with anti-p38,
ERK1/2, JNK MAPK, RUNX-2 (Abnova, Taipei, Taiwan), anti-
phospho-p38, p44/42, JNK MAPK (Cell Signaling Technology, Bev-
erly, MA, USA), anti-phospho-RUNX-2 (Cell Signaling Technology),
histone H3, and acetyl-histone H3 (Lys9) (Cell Signaling Tech-
nology) antibodies at a dilution of 1:1000 (1:2000 for phospho-
p38, histone H3, and acetyl-histone H3) in CanGet Signal
Immunoreaction Enhancer Solution (TOYOBO). After washing,
the membranes were stained with the appropriate horseradish
peroxidase-conjugated anti-mouse secondary antibody (diluted
1:10,000, R&D Systems) or anti-rabbit secondary antibody (diluted
1:10,000, Bethyl Laboratories, Montgomery, TX, USA) at room
temperature for 1 h. We detected immunoreactive proteins using
the Enhanced Chemiluminescence (ECL) Detection System (GE
Healthcare, Buckinghamshire, UK).
Statistical analysis
All datawere expressed as themeans 95% conﬁdence intervals
(CI). All experiments were repeated at least ﬁve times and similar
results were acquired. Differences among groups were analyzed
using a one-way analysis of variance (ANOVA) with Bonferroni
post-hoc test (SPSS Inc., Chicago, IL, USA). A P-value< 0.05 was
considered statistically signiﬁcant.
Results
HDAC inhibitors have an effect on the viability of cultured human
chondrocytes
Both TSA and MS-275, at concentrations of 500 nM, inhibited
chondrocytic proliferation to about 50% (Table II). MS-275
concentrations of 10 and 100 nM and TSA concentration of 10 nM
did not reduce cell proliferation. The results of western blotting
conﬁrmed that histone H3 was acetylated by TSA or MS-275 at 10,
100, 500 nM concentrations without CTS (Supplemental Fig. 2).
HDAC inhibitors upregulate COL2A1 and downregulate CTS-induced
RUNX-2, ADAMTS-5, and MMP-3 gene expression
The human chondrocytes used in this study continued to
express type II collagen, even though they were grown in mono-
layers. COL2A1 expression in human chondrocytes was decreased
by CTS and increased after treatment with 10 nM of TSA and
100 nM of MS-275. These effects were not noted after 100 nM orthe MTT assay
þ þ þ þ
100  500 
 100  500
0.88* 1.37* 0.54* 0.56*
1.40 0.80e0.95 1.29e1.44 0.46e0.61 0.49e0.63
elative to CTS () and HDAC inhibitors ().
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regulated by 500 nM of MS-275. RUNX-2, ADAMTS-5, MMP-3, and
MMP-13 expressions were upregulated by CTS and CTS-induced
expression of RUNX-2, ADAMTS-5, and MMP-3 was down-
regulated by TSA or MS-275 at concentrations of 10, 100, 500 nM
(Fig. 1). CTS-induced expression of MMP-13 was downregulated by
MS-275 at concentrations of 10, 100, 500 nM. These results lead us
to perform subsequent experiments with TSA at 10 nM andMS-275
at 100 nM.
The results of real-time PCR showed that COL2A1 expression
was increased by 10 nM of TSA and 100 nM ofMS-275, regardless of
CTS addition. CTS-induced upregulation of RUNX-2, ADAMTS-5,
andMMP-3 was signiﬁcantly downregulated by the treatment with
10 nM of TSA and 100 nM of MS-275. Treatment of the cells by
10 nM of TSA and 100 nM of MS-275 without CTS did not affect
the expression of RUNX-2, ADAMTS-5, and MMP-3 [Fig. 2(AeD)].
These results were conﬁrmed using human chondrocyte-like cells
(SW1353) and NHAC-kn cells from an 18-year-old male, and
obtained similar results (data not shown). MMP-13 expression
tended to be upregulated by CTS and downregulated by HDAC
inhibitors, however, the differences were not signiﬁcant [Fig. 2(E)].RUNX-2
ADAMTS-5
G3PDH
(nM)
CTS - + + + +
TSA - - 10 100 500
RUNX-2
ADAMTS-5
G3PDH
A
B
COL2A1
COL2A1
MMP-3
MMP-3
(nM)
CTS - + + + +
MS-275 - - 10 100 500
MMP-13
MMP-13
Fig. 1. RT-PCR results showed changes in COL2A1, RUNX-2, ADAMTS-5, and MMP-3
gene expression with various concentrations of TSA (A) and MS-275 (B) in human
chondrocytes. After CTS, the expressions of RUNX-2, ADAMTS-5, and MMP-3 were
upregulated without HDAC inhibitors, but were not upregulated in the presence of
HDAC inhibitors. In contrast, COL2A1 was suppressed after CTS without HDAC inhib-
itors, but not suppressed with TSA (10, 100, 500 nM) or MS-275 (100 nM). The PCR
ampliﬁcations were repeated at least ﬁve times and similar results were acquired.HDAC inhibitors suppress CTS-induced increases in RUNX-2 and
ADAMTS-5 protein expression
RUNX-2 expression was upregulated and localized to the nucleus
following CTS without HDAC inhibitors, but was not upregulated by
incubation with HDAC inhibitors [Fig. 3(A), RUNX-2, green signals].
Similarly, ADAMTS-5 expression was upregulated and localized in
the cytoplasm after CTS without HDAC inhibitors, but was not
upregulated with HDAC inhibitors [Fig. 3(A), ADAMTS-5, green
signals]. The positive cell ratios for RUNX-2 and ADAMTS-5 after CTS
without HDAC inhibitors were 70.310.5% and 67.410.6%,
respectively. The positive cell ratios in the other models were
<9.17.1%.
HDAC inhibitors regulate the activation of RUNX-2 in human
chondrocytes
We investigated the change in RUNX-2 phosphorylation with
and without HDAC inhibitors by western blotting. RUNX-2 phos-
phorylation increased after CTS andwas signiﬁcantly suppressed by
HDAC inhibitors (P< 0.001) (Fig. 4).
HDAC inhibitors regulate the activation of MAPK in human
chondrocytes
Mechanical stress can activate stress response signaling path-
ways, such as MAPK. Thus, we investigated MAPK phosphorylation
(p38, JNK, and ERK) with and without HDAC inhibitors after CTS by
western blotting. CTS signiﬁcantly increased the phosphorylation
of ERK and p38 at 60 min compared to the non-stretched controls
(P< 0.001) [Fig. 5(A, C)]. HDAC inhibitors signiﬁcantly inhibited
the mechanical stress-induced phosphorylation of ERK and p38
(P< 0.001). JNK phosphorylation tended to increase compared to
non-stretched controls (P¼ 0.158) and was inhibited by HDAC
inhibitors (TSA: P< 0.001, MS-275: P¼ 0.534) [Fig. 5(B)].
Discussion
Chondrocytes are responsive to mechanical stress at both the
protein and mRNA levels. During normal movement, articular
cartilage experiences compression loads of up to 15%, which results
in up to a 5% increase in chondrocytic elongation30. Although
chondrocytes are directly compressed during the loading of normal
cartilage, it is very probable that thematrix components of the ECM
network, which are connected to the chondrocytes, stretch the cells
during compression of cartilage31.
It is clear that the protein catabolic enzymes, such as MMPs and
ADAMTSs, play important roles in the degradation of cartilage.
MMPs and ADAMTS inhibitors do not have an obvious beneﬁcial
effect on OA due to side effects, such as ostealgia, myalgia, and
tendovaginitis32. Therefore, the upstream regulators of these
enzymes are potentially key candidates for the targeted OA therapy.
However, the regulatory mechanisms of mechanical stress on these
enzymes are largely unknown.
The ADAMTS-5 promoter has a RUNX-2 binding site33, sug-
gesting that ADAMTS-5 is a potential downstream target of
RUNX-2. Our report has shown that RUNX-2 is an upstream regu-
lator of the mechanical stress-induced ADAMTS-5, suggesting that
RUNX-2 could be a target gene in matrix degradation17.
HDAC inhibitors have been investigated as anticancer
compounds, largely by virtue of their inﬂuence on the cell cycle and
apoptosis in transformed cells34. Recent reports suggested the
efﬁcacy of HDAC inhibitors as a therapy for arthritis. The action of
HDAC inhibitors on cytokine-induced chondrocyte gene expression
was ﬁrst demonstrated by Young et al.35, who reported that the
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Fig. 2. The effects of HDAC inhibitors (TSA: 10 nM, MS-275: 100 nM) on COL2A1, RUNX-2, ADAMTS-5, MMP-3 and MMP-13 expression in human chondrocytes. Changes in COL2A1
mRNA expression after 10% mechanical stretch in human chondrocytes (A). Real-time PCR analyses (n¼ 6 per experimental group) showed that COL2A1mRNA expression decreased
15 h after CTS without HDAC inhibitors. In the presence of HDAC inhibitors, COL2A1 mRNA expression after CTS decreased relative to CTS (), however, the expression increased
relative to the absence of HDAC inhibitors. After CTS, the expression of RUNX-2, ADAMTS-5, and MMP-3 was upregulated without HDAC inhibitors and was not upregulated with
HDAC inhibitors (B, C, D). MMP-13 expression tended to increase with CTS and decrease with HDAC inhibitor treatment (E). Relative mRNA levels of each gene were normalized to
G3PDH controls and were plotted relative to CTS () and HDAC inhibitors (). The data are presented as the mean with 95% CI. *P< 0.05, **P< 0.001. xP¼ 0.10, xxP¼ 1.00.
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Fig. 3. The effects of mechanical stress and HDAC inhibitors on protein expressions of RUNX-2 and ADAMTS-5 in human chondrocytes. RUNX-2 expression was upregulated and
localized to the nucleus following CTS without HDAC inhibitors (green signals). ADAMTS-5 expression was upregulated and localized in the cytoplasm after CTS without HDAC
inhibitors (green signals). These CTS-induced protein expression were suppressed by both TSA (10 nM) and MS-275 (100 nM). Merged images with the staining by phalloidin and
Hoechst 33342 were shown in the right-side panels. Cells incubated without primary antibodies were used as controls (lower panel) (A). Arrows denote the direction of stretching.
Scale bar¼ 100 mm. The cell count data via immunocytochemistry is shown in (B). The results are expressed as a percentage of RUNX-2 or ADAMTS-5 positive cell ratios (number of
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Fig. 4. Western blot analysis showed RUNX-2 phosphorylation 30 min after CTS in human chondrocytes. Total protein extracts were subjected to SDS-PAGE (10 mg of total protein/
lane), and western blot analysis was performed with total and phosphorylated RUNX-2 (P-RUNX-2) antibodies. RUNX-2 expression was upregulated without HDAC inhibitors, but
was not upregulated with HDAC inhibitors. The data are presented as the mean with 95% CI of six determinations. *P< 0.001.
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MMPs and ADAMTSs were suppressed by TSA in human chon-
drosarcoma cell lines and human chondrocytes. MMP-13 expres-
sion was reportedly controlled by MAPK through RUNX-2
activation17,36. Furthermore, several reports showed that nuclear
factor (NF)-kB pathways activated by IL-1 and tumor necrosis factor
(TNF)-a regulated MMP-13 expression37,38. In our study, CTS-
induced MMP-13 expression was not signiﬁcantly downregulated
by either HDAC inhibitors, nevertheless MAPK and RUNX-2 acti-
vation were suppressed. MMP-13 expression was not upregulated
signiﬁcantly within 1 h after CTS, which is consistent with our
previous result that signiﬁcant MMP-13 upregulation was seen
12e24 h after CTS17. Hence, MMP-13 expression might be inﬂu-
enced by CTS-activated NF-kB pathways or other cytokines, and our
experimental protocol in the current study to examine the early
response to CTS might have failed to detect the later changes of
MMP-13 and the inﬂuence of HDAC inhibitors.
In the present study, CTS-induced RUNX-2, ADAMTS-5, and
MMP-3 mRNA expression were downregulated by treatment with
HDAC inhibitors. In contrast, treatment with HDAC inhibitors led to
an upregulation of COL2A1 mRNA expression. Therefore, treatment
with HDAC inhibitors can both decrease catabolic effects and
increase anabolic effects. Huh et al.39 reported HDAC-induced
COL2A1 suppression in rabbit chondrocytes. Whereas, Furumatsu
et al.40 showed that HDAC enhanced COL2A1 expression in human
chondrocytes. This discrepancy may be caused by species differ-
ence. We used human chondrocytes and our results were consis-
tent with those of Furumatsu et al., who demonstrated that
histones H3/H4 around the COL2A1 enhancer region were highly
acetylated by HDAC inhibitor treatments by chromatin immuno-
precipitation assays. HDAC inhibitor at concentrations of 500 nM
decreased cell proliferation by approximately half (Table II). Hence,
COL2A1 might be upregulated by TSA at a concentration of 10 nM
or MS-275 at a concentration of 100 nM, while downregulated at
higher concentrations probably by decreasing cell proliferation and
viability.
The MAPK pathway, involving p38, JNK, and ERK activity, has
been shown to be modulated by diverse external stimuli, such as
cytokines and physical stresses, which are transduced to the
intracellular environment by mechanoreceptors13,41. RUNX-2
regulation by mechanical stress is thought to be mediated by
speciﬁc MAPK pathways16,17,42e44. In particular, MEK/ERK signaling
showed a strong correlation between cell surface integrinactivation and subsequent stimulation of RUNX-2-dependent
transcription11e13. RUNX-2 activity is controlled by phosphoryla-
tion; another group demonstrated that RUNX-2 was phosphory-
lated by ERK1/2 and p38 in response to mechanical stress16,17. We
previously reported that p38 was phosphorylated by mechanical
stress in a human chondrosarcoma cell line (SW1353)17. Here, we
demonstrated that ERK1/2, p38, and JNK were phosphorylated by
mechanical stress in human chondrocytes. This discrepancymay be
explained by cell type differences.
Previous studies suggested that HDAC inhibitors regulate the
MAPK pathway in several cancer cell lines45e48. It was reported that
phosphorylation of ERK and JNK was decreased following the
treatment of human K562 leukemia cells with butyrate48. Another
report showed that valproic acid (VPA) and TSA blocked ERK and
Akt activation in mouse C3H10T1/2 ﬁbroblasts and that TSA also
downregulated JNK phosphorylation47. In Ras-transformed 10T1/2
cells, Fecteau et al.49 showed that the HDAC inhibitor FR901228 also
suppressed the ERK and p38 pathways. Therefore, HDAC inhibitors
can modulate a number of intracellular signaling cascades in
response to mechanical stress in human normal chondrocytes. The
current study demonstrated that HDAC inhibitors reduced CTS-
induced phosphorylation of ERK1/2, p38, and JNK in human
chondrocytes. These ﬁndings suggested that HDAC inhibitors
suppress RUNX-2 and ADAMTS-5 expression by downregulating
MAPK signaling. Therefore, the current study is the ﬁrst to
demonstrate that HDAC inhibitors decrease mechanical stress-
induced MAPK phosphorylation and the resulting catabolic
effects; however, the precise mechanism of this decrease remains
unknown. Previous reports have suggested that HDAC inhibitors
induce apoptosis in several types of tumor cells through cell cycle
arrest mediated by the cyclin-dependent kinase (CDK) inhibitor
p21WAF1/Cip120e22,50e52. We previously showed that HDAC inhibi-
tors increase the expression of the CDK inhibitors p16 and p2124.
Other groups have reported that p21 suppressed p38 activity and
reduced the secretion of proinﬂammatory cytokines in Toll-like
receptor-stimulated macrophages53 and that p21 suppressed JNK
activity and the IL-1-triggered activation of IL-6, IL-8, MCP-1, MIP-
3a, MMP-1 and -3 in rheumatoid synovial ﬁbroblasts54. These
results suggested that the activation of CDK inhibitors by HDAC
inhibitors may contribute to the suppression of the MAPK pathway.
There are several limitations in the current study. First, the
stretch system was a simple experimental model for OA in vitro
experiments using cells in a monolayer; however, it remains
00.5
1
1.5
2
2.5
P-JNK/JNK
total-ERK
phospho-ERK
total-JNK
phospho-JNK
total-p38
phospho-p38
*
**
*
*
**
CTS
- + - + - +
TSA
- - 10 10 - -
MS-275
- - - - 100 100
CTS
- + - + - +
TSA
- -
10 10
- -
MS-
275 - - - - 100 100
CTS
- + - + - +
TSA
- - 10 10 - -
MS-275
- - - - 100 100
CTS
- + - + - +
TSA
- -
10 10
- -
MS-
275 - - - - 100 100
CTS
- + - + - +
TSA
- - 10 10 - -
MS-275
- - - - 100 100
CTS
- + - + - +
TSA
- -
10 10
- -
MS-
275 - - - - 100 100
(nM)
(nM)
(nM)
(nM)
(nM)
(nM)
0
0.5
1
1.5
2
2.5
3
3.5
P-ERK/ERK
0
0.5
1
1.5
2
2.5
3
P-p38/p38
A
B
C
Fig. 5. The western blots were probed for total JNK and phosphorylated JNK (P-JNK) (A), total ERK1/2 and phosphorylated ERK1/2 (P-ERK1/2) (B), or total p38 and phosphorylated
p38 (P-p38) (C). The fold increase in phosphorylation based on densitometry analysis of western blots. Results of western blotting and densitometry showed phosphorylation of
ERK, JNK, and p38 in human chondrocytes after CTS for 30 min. Total protein extracts were subjected to SDS-PAGE (10 mg of total protein/lane). The data were presented as the
mean with 95% CI of six determinations. *P< 0.001. xP¼ 0.158, xxP¼ 0.534.
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three dimensions and the efﬁcacy of HDAC inhibitors for articular
cartilage protection in vivo. Second, it was not clear which HDAC is
the therapeutic target for cartilage degradation. Based on the result
that both TSA and MS-275 showed inhibitory effects on the
mechanical stress-induced expression of catabolic enzymes, it is
reasonable to consider that the therapeutic candidates are included
in class I HDACs, such as HDAC 1, 2, 3, and 8. Third, further inves-
tigations are required to demonstrate the efﬁcacy of HDAC inhibi-
tors using in vivo experiments with an animal OAmodel of cartilage
destruction.
In conclusion, the results of the current study demonstrated that
HDAC inhibitors may function as potent repressors of the expres-
sion of matrix-degrading proteases, such as ADAMTS-5 andMMP-3,
induced by mechanical stress via the inhibition of RUNX-2 and the
activation of MAPK in chondrocytes.
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